Cargando…
Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
BACKGROUND: DNA methylation biomarkers for early detection, risk stratification and treatment response in cancer have been of great interest over the past decades. Nevertheless, clinical implementation of these biomarkers is limited, as only < 1% of the identified biomarkers is translated into a...
Autores principales: | Massen, Maartje, Lommen, Kim, Wouters, Kim A. D., Vandersmissen, Johan, van Criekinge, Wim, Herman, James G., Melotte, Veerle, Schouten, Leo J., van Engeland, Manon, Smits, Kim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047347/ https://www.ncbi.nlm.nih.gov/pubmed/35477541 http://dx.doi.org/10.1186/s13148-022-01273-z |
Ejemplares similares
-
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC
por: Rademakers, Glenn, et al.
Publicado: (2021) -
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
por: Derks, Sarah, et al.
Publicado: (2013) -
Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
por: Draht, Muriel X. G., et al.
Publicado: (2016) -
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
por: Draht, Muriel X. G., et al.
Publicado: (2018) -
Nervous NDRGs: the N-myc downstream–regulated gene family in the central and peripheral nervous system
por: Schonkeren, Simone L., et al.
Publicado: (2019)